Mark Hopman
CIK: 0002048497
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Beta Bionics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (34 total)
- Oct 26, 2026BBNX
Beta Bionics, Inc.
Sale(S)Direct821 shares at avg. $20.00$16K - Oct 14, 2026BBNX
Beta Bionics, Inc.
Sale(S)Direct775 shares at avg. $17.35$13K - Oct 1, 2026BBNX
Beta Bionics, Inc.
Sale(S)Direct370 shares at avg. $18.96$7K - Sep 16, 2026BBNX
Beta Bionics, Inc.
Sale(S)Direct30.8K shares at avg. $20.13$620K - Sep 14, 2026BBNX
Beta Bionics, Inc.
Sale(S)Direct775 shares at avg. $15.52$12K - Sep 9, 2026BBNX
Beta Bionics, Inc.
Sale(S)Direct36K shares at avg. $18.46$665K - Sep 2, 2026BBNX
Beta Bionics, Inc.
Sale(S)Direct5.3K shares at avg. $19.11$102K - Jun 24, 2026BBNX
Beta Bionics, Inc.
Sale(S)Direct1.3K shares at avg. $15.01$19K - Jun 4, 2026BBNX
Beta Bionics, Inc.
Sale(S)Direct275 shares at avg. $12.31$3K - Jun 2, 2026BBNX
Beta Bionics, Inc.
Sale(S)Direct5.3K shares at avg. $12.61$67K - Mar 4, 2026BBNX
Beta Bionics, Inc.
Sale(S)Direct353 shares at avg. $11.57$4K - Mar 2, 2026BBNX
Beta Bionics, Inc.
Sale(S)Direct834 shares at avg. $12.36$10K - Feb 27, 2026BBNX
Beta Bionics, Inc.
Award(A)DirectEmployee Stock Option (right to buy)
91.5K shares- - Feb 27, 2026BBNX
Beta Bionics, Inc.
Award(A)Direct109.1K shares- - Dec 4, 2025BBNX
Beta Bionics, Inc.
Sale(S)Direct2.1K shares at avg. $30.66$63K - Dec 2, 2025BBNX
Beta Bionics, Inc.
Sale(S)Direct856 shares at avg. $29.34$25K - Sep 5, 2025BBNX
Beta Bionics, Inc.
Sale(S)Direct11.4K shares at avg. $20.56$235K - Sep 5, 2025BBNX
Beta Bionics, Inc.
Exercise(M)Direct11.4K shares at avg. $5.10$58K - Sep 4, 2025BBNX
Beta Bionics, Inc.
Exercise(M)Direct656 shares at avg. $5.10$3K - Sep 4, 2025BBNX
Beta Bionics, Inc.
Sale(S)Direct6.8K shares at avg. $19.97$136K - Sep 4, 2025BBNX
Beta Bionics, Inc.
Exercise(M)Direct4.1K shares at avg. $5.10$21K - Sep 2, 2025BBNX
Beta Bionics, Inc.
Sale(S)Direct848 shares at avg. $18.86$16K - Aug 19, 2025BBNX
Beta Bionics, Inc.
Sale(S)Direct16.2K shares at avg. $16.61$268K - Aug 19, 2025BBNX
Beta Bionics, Inc.
Exercise(M)Direct16.2K shares at avg. $5.10$82K - Jun 2, 2025BBNX
Beta Bionics, Inc.
Sale(S)Direct79 shares at avg. $18.69$1K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 26, 2026 | BBNX Beta Bionics, Inc. | Sale(S) | 821 | $20.00 | $16,420 | Direct |
| Oct 14, 2026 | BBNX Beta Bionics, Inc. | Sale(S) | 775 | $17.35 | $13,446 | Direct |
| Oct 1, 2026 | BBNX Beta Bionics, Inc. | Sale(S) | 370 | $18.96 | $7,015 | Direct |
| Sep 16, 2026 | BBNX Beta Bionics, Inc. | Sale(S) | 30,779 | $20.13 | $619,640 | Direct |
| Sep 14, 2026 | BBNX Beta Bionics, Inc. | Sale(S) | 775 | $15.52 | $12,028 | Direct |
| Sep 9, 2026 | BBNX Beta Bionics, Inc. | Sale(S) | 35,994 | $18.46 | $664,550 | Direct |
| Sep 2, 2026 | BBNX Beta Bionics, Inc. | Sale(S) | 5,327 | $19.11 | $101,815 | Direct |
| Jun 24, 2026 | BBNX Beta Bionics, Inc. | Sale(S) | 1,258 | $15.01 | $18,880 | Direct |
| Jun 4, 2026 | BBNX Beta Bionics, Inc. | Sale(S) | 275 | $12.31 | $3,385 | Direct |
| Jun 2, 2026 | BBNX Beta Bionics, Inc. | Sale(S) | 5,329 | $12.61 | $67,183 | Direct |
| Mar 4, 2026 | BBNX Beta Bionics, Inc. | Sale(S) | 353 | $11.57 | $4,084 | Direct |
| Mar 2, 2026 | BBNX Beta Bionics, Inc. | Sale(S) | 834 | $12.36 | $10,310 | Direct |
| Feb 27, 2026 | BBNX Beta Bionics, Inc. | Award(A) Employee Stock Option (right to buy) | 91,520 | - | - | Direct |
| Feb 27, 2026 | BBNX Beta Bionics, Inc. | Award(A) | 109,105 | - | $0 | Direct |
| Dec 4, 2025 | BBNX Beta Bionics, Inc. | Sale(S) | 2,061 | $30.66 | $63,192 | Direct |
| Dec 2, 2025 | BBNX Beta Bionics, Inc. | Sale(S) | 856 | $29.34 | $25,112 | Direct |
| Sep 5, 2025 | BBNX Beta Bionics, Inc. | Sale(S) | 11,411 | $20.56 | $234,657 | Direct |
| Sep 5, 2025 | BBNX Beta Bionics, Inc. | Exercise(M) | 11,411 | $5.10 | $58,196 | Direct |
| Sep 4, 2025 | BBNX Beta Bionics, Inc. | Exercise(M) | 656 | $5.10 | $3,346 | Direct |
| Sep 4, 2025 | BBNX Beta Bionics, Inc. | Sale(S) | 6,818 | $19.97 | $136,180 | Direct |
| Sep 4, 2025 | BBNX Beta Bionics, Inc. | Exercise(M) | 4,093 | $5.10 | $20,874 | Direct |
| Sep 2, 2025 | BBNX Beta Bionics, Inc. | Sale(S) | 848 | $18.86 | $15,996 | Direct |
| Aug 19, 2025 | BBNX Beta Bionics, Inc. | Sale(S) | 16,158 | $16.61 | $268,376 | Direct |
| Aug 19, 2025 | BBNX Beta Bionics, Inc. | Exercise(M) | 16,158 | $5.10 | $82,406 | Direct |
| Jun 2, 2025 | BBNX Beta Bionics, Inc. | Sale(S) | 79 | $18.69 | $1,477 | Direct |
1-25 of 34 transactions
About Hopman Mark
Hopman Mark (SEC CIK 0002048497) files insider reports with the SEC as Chief Commercial Officer of Beta Bionics, Inc. (BBNX).
Signal8 holds 23 ownership filings by Hopman Mark (1 Form 3, 22 Form 4), filed between Jan 29, 2025 and Oct 28, 2026. Those filings report 34 transactions, from Jan 29, 2025 to Oct 26, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Hopman Mark's filings is in IRVINE, CA.
Recent filings by Hopman Mark
- Oct 26, 2026: Open-market sale of BBNX shares (Form 4, code S).
- Oct 14, 2026: Open-market sale of BBNX shares (Form 4, code S).
- Oct 1, 2026: Open-market sale of BBNX shares (Form 4, code S).
- Sep 16, 2026: Open-market sale of BBNX shares (Form 4, code S).
- Sep 14, 2026: Open-market sale of BBNX shares (Form 4, code S).
Other insiders filing for Beta Bionics, Inc. (BBNX)
- Mensinger Mike, Chief Product Officer
- Jones Christy, Director
- Saint Sean, President & CEO
- Russell Steven Jon, Chief Medical Officer
- Feider Stephen, Chief Financial Officer
- MICHEL GERARD J, Director